In Synovial Sarcoma, KIF23 was involved in metastasis, leading to reduced survival.[12] A recent study found that a lncRNA PVT1 knockdown reduced KIF23 expression by enhancing miR-15a-5p, thereby attenuating prostate cancer progression.[13] Nonetheless, the roles of KIF23 in DLBCL remain unclear. Here, KIF23 is linked to prostate cancer.